Indeed it appears that in DM1 a combined effect of decreased MBNL1 and increased CUGBP1 activity lead to misregulated alternative splicing and other changes of the muscle transcriptome [5], [34]. The gene discussed is MBNL1; the disease is myotonic dystrophy type 1.